Citation

Jaafar NRN, Daud TIM, Rahman FNA, Baharudin A. Aust. N. Zeal. J. Psychiatry 2007; 41(9): 768-769.

Copyright

(Copyright © 2007, Royal Australian and New Zealand College of Psychiatrists, Publisher SAGE Publishing)

DOI

10.1080/00048670701517983

PMID

17687663

Abstract

OBJECTIVE: To report the use of Mirtazapine in the treatment of anorexia nervosa with depression primarily regarding its propensity for weight gain.
METHOD: We present an outpatient case report of anorexia nervosa with depression. The patient's subsequent progress was recorded.
RESULTS: The patient gained 2.5 kg within 3 months to eventually attain a body mass index of 15 after 5 months. Her depression achieved full remission at 6 weeks of treatment.
CONCLUSIONS: Mirtazapine is the choice medication in this case. However, treating depression requires caution, given these patients' physical vulnerability. Controlled trials of Mirtazapine for anorexia nervosa are needed.

Language: en

Keywords

Adolescent; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Body Weight; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Family Therapy; Female; Humans; Mianserin; Mirtazapine; Patient Care Team; Suicide; Suicide Prevention